Advertisement
Australia markets closed
  • ALL ORDS

    8,022.90
    -54.00 (-0.67%)
     
  • AUD/USD

    0.6662
    +0.0012 (+0.18%)
     
  • ASX 200

    7,783.00
    -55.80 (-0.71%)
     
  • OIL

    81.57
    +0.74 (+0.92%)
     
  • GOLD

    2,322.70
    -8.10 (-0.35%)
     
  • Bitcoin AUD

    91,881.03
    -46.15 (-0.05%)
     
  • CMC Crypto 200

    1,272.64
    -11.14 (-0.87%)
     

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

PHILADELPHIA, May 30, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6th at 3:00 pm ET.

(PRNewsfoto/CARISMA Therapeutics Inc.)
(PRNewsfoto/CARISMA Therapeutics Inc.)

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

ADVERTISEMENT

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-302158376.html

SOURCE Carisma Therapeutics Inc.